Jennifer S. Laurence

Jennifer S. Laurence

Auto-generated profile, based on publicly available information

Jennifer S. Laurence

The Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2013 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
NBNicholas J. Boylan
Nicholas J. Boylan
WZWen Zhou
Wen Zhou
RPRobert J. Proos
Robert J. Proos
TTThomas J. Tolbert
Thomas J. Tolbert
JWJanet L. Wolfe
Janet L. Wolfe
JLJennifer S. Laurence
Jennifer S. Laurence

1 November 2008 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
ASAndria L. Skinner
Andria L. Skinner
JLJennifer S. Laurence
Jennifer S. Laurence

1 May 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DED. Fernando Estrada
D. Fernando Estrada
ASAndria L. Skinner
Andria L. Skinner
JLJennifer S. Laurence
Jennifer S. Laurence
ESEmily Scott
Emily Scott
Crystallographic studies of different membrane cytochrome P450 enzymes have provided examples of distinct structural conformations, suggesting protein flexibility. It has been speculated that conformational selection is an integral component of substrate recognition and access, but direct evidence of such substate interconversion has thus far remained elusive. In the current study, solution NMR revealed multiple and exchanging backbone conformations for certain structural features of the human steroidogenic cytochrome P450 17A1 (CYP17A1). This bifunctional enzyme is responsible for pregnenolone C17 hydroxylation, followed by a 17,20-lyase reaction to produce dehydroepiandrosterone, the key intermediate in human synthesis of androgen and estrogen sex steroids. The distribution of CYP17A1 conformational states was influenced by temperature, binding of these two substrates, and binding of the soluble domain of cytochrome b5 (b5). Notably, titration of b5 to CYP17A1·pregnenolone induced a set of conformational states closely resembling those of CYP17A1·17α-hydroxypregnenolone without b5, providing structural evidence consistent with the reported ability of b5 to selectively enhance 17,20-lyase activity. Solution NMR thus revealed a set of conformations likely to modulate human steroidogenesis by CYP17A1, demonstrating that this approach has the potential to make similar contributions to understanding the functions of other membrane P450 enzymes involved in drug metabolism and disease states.

1 February 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DED.FErnand. Estrada
D.FErnand. Estrada
JLJennifer S. Laurence
Jennifer S. Laurence
ESEmily Scott
Emily Scott
To accomplish key physiological processes ranging from drug metabolism to steroidogenesis, human microsomal cytochrome P450 enzymes require the sequential input of two electrons delivered by the FMN domain of NADPH-cytochrome P450 reductase. Although some human microsomal P450 enzymes can instead accept the second electron from cytochrome b5, for human steroidogenic CYP17A1, the cytochrome P450 reductase FMN domain delivers both electrons, and b5 is an allosteric modulator. The structural basis of these key but poorly understood protein interactions was probed by solution NMR using the catalytically competent soluble domains of each protein. Formation of the CYP17A1·FMN domain complex induced differential line broadening of the NMR signal for each protein. Alterations in the exchange dynamics generally occurred for residues near the surface of the flavin mononucleotide, including 87–90 (loop 1), and for key CYP17A1 active site residues. These interactions were modulated by the identity of the substrate in the buried CYP17A1 active site and by b5. The FMN domain outcompetes b5 for binding to CYP17A1 in the three-component system. These results and comparison with previous NMR studies of the CYP17A1·b5 complex suggest a model of CYP17A1 enzyme regulation.

9 December 2009 in Inorganic Chemistry
Verified
Journal Article
Closed access
MKMary E. Krause
Mary E. Krause
AGAmanda M. Glass
Amanda M. Glass
TJTimothy A. Jackson
Timothy A. Jackson
JLJennifer S. Laurence
Jennifer S. Laurence

2 April 2009 in Biochemistry
Verified
Journal Article
Closed access
ASAndria L. Skinner
Andria L. Skinner
AVAnthony A. Vartia
Anthony A. Vartia
TWTodd D. Williams
Todd D. Williams
JLJennifer S. Laurence
Jennifer S. Laurence